Bifogade filer
Interim Report Q1 2025
Kurs
-6,94%
Likviditet
7,24 MSEK
Prenumeration
Kalender
| Est. tid* | ||
| 2026-02-12 | 08:00 | Bokslutskommuniké 2025 |
| 2025-10-23 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-17 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-09 | N/A | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2025-05-07 | N/A | Årsstämma |
| 2025-04-24 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-13 | - | Bokslutskommuniké 2024 |
| 2024-10-24 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-18 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-10 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2024-05-08 | - | Årsstämma |
| 2024-04-25 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-16 | - | Bokslutskommuniké 2023 |
| 2023-12-29 | - | Extra Bolagsstämma 2023 |
| 2023-10-26 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-14 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-08 | - | X-dag ordinarie utdelning STIL 1.80 SEK |
| 2023-05-05 | - | Årsstämma |
| 2023-04-27 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-17 | - | Bokslutskommuniké 2022 |
| 2022-10-27 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-15 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-06 | - | X-dag ordinarie utdelning STIL 1.00 SEK |
| 2022-05-05 | - | Årsstämma |
| 2022-05-01 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-10-27 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-16 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-05 | - | X-dag ordinarie utdelning STIL 1.70 SEK |
| 2021-05-04 | - | Årsstämma |
| 2021-04-28 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-18 | - | Bokslutskommuniké 2020 |
| 2020-10-29 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-20 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-28 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2020-05-27 | - | Årsstämma |
| 2020-04-29 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-20 | - | Bokslutskommuniké 2019 |
| 2019-10-31 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-22 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-03 | - | X-dag ordinarie utdelning STIL 1.45 SEK |
| 2019-05-02 | - | Årsstämma |
| 2019-05-02 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-25 | - | Bokslutskommuniké 2018 |
| 2018-11-22 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-23 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-17 | - | Kvartalsrapport 2018-Q1 |
| 2018-04-23 | - | X-dag ordinarie utdelning STIL 1.20 SEK |
| 2018-04-20 | - | Årsstämma |
| 2018-02-22 | - | Bokslutskommuniké 2017 |
| 2017-11-16 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-24 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-18 | - | Kvartalsrapport 2017-Q1 |
| 2017-04-27 | - | X-dag ordinarie utdelning STIL 1.00 SEK |
| 2017-04-26 | - | Årsstämma |
| 2017-02-16 | - | Bokslutskommuniké 2016 |
| 2016-11-17 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-25 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-19 | - | Kvartalsrapport 2016-Q1 |
| 2016-04-29 | - | X-dag ordinarie utdelning STIL 0.80 SEK |
| 2016-04-28 | - | Årsstämma |
| 2016-02-18 | - | Bokslutskommuniké 2015 |
| 2015-11-17 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-25 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-19 | - | Kvartalsrapport 2015-Q1 |
| 2015-04-16 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2015-04-15 | - | Årsstämma |
| 2015-02-18 | - | Bokslutskommuniké 2014 |
| 2014-11-19 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-28 | - | Kvartalsrapport 2014-Q2 |
| 2014-07-30 | - | X-dag ordinarie utdelning STIL 1.00 SEK |
| 2014-05-14 | - | Kvartalsrapport 2014-Q1 |
| 2014-04-03 | - | Årsstämma |
| 2014-02-20 | - | Bokslutskommuniké 2013 |
| 2013-11-28 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-29 | - | Kvartalsrapport 2013-Q2 |
| 2013-05-28 | - | Kvartalsrapport 2013-Q1 |
| 2013-04-26 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2013-04-25 | - | Årsstämma |
| 2013-02-20 | - | Bokslutskommuniké 2012 |
| 2012-11-20 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-29 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-16 | - | Kvartalsrapport 2012-Q1 |
| 2012-04-19 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2012-04-18 | - | Årsstämma |
| 2012-02-15 | - | Bokslutskommuniké 2011 |
| 2011-11-16 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-24 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-18 | - | Kvartalsrapport 2011-Q1 |
| 2011-04-14 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2011-04-13 | - | Årsstämma |
| 2011-02-16 | - | Bokslutskommuniké 2010 |
| 2010-11-24 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-18 | - | Kvartalsrapport 2010-Q2 |
| 2010-04-16 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2010-04-15 | - | Kvartalsrapport 2010-Q1 |
| 2010-02-19 | - | Bokslutskommuniké 2009 |
| 2009-11-20 | - | Kvartalsrapport 2009-Q3 |
| 2009-08-27 | - | Kvartalsrapport 2009-Q2 |
| 2009-05-15 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2009-05-14 | - | Kvartalsrapport 2009-Q1 |
| 2009-04-15 | - | Årsstämma |
| 2008-06-24 | - | Split STIL 100:1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Stille AB (publ) today presents the report for the first quarter 2025.
Revenue amounted to 129.3 MSEK (139.7) impacted by temporary delivery restrictions and the phase-out of non-strategic products.
“Stille starts 2025 with a quarter marked by temporary challenges.” says Torbjörn Sköld but also points out,“Order intake
remained strong, in line with financial targets, providing good conditions for recovery and growth during the rest of the year”
The gross profit amounted to 51.1 percent (48.6) and EBIT before one-time costs amounted to 17.9 MSEK (27.0).
” In June 2025, I will step down as CEO. The Board is currently conducting a thorough recruitment process to ensure continuity of leadership and maintain the company’s strategic direction. I leave my role with full confidence in the Stille team, the company’s strategy and the future”, concludes Stille’s CEO.
| MSEK | JAN-MAR 2025 | JAN-MAR 2024 | APR-MAR 2024/2025 | JAN-DEC 2024 |
| Net sales | 129.3 | 139.7 | 559.6 | 569.9 |
| Gross profit, % | 51.1 | 48.6 | 52.5 | 51.9 |
| EBITDA before non-recurring items | 25.2 | 33.7 | 134.0 | 142.4 |
| EBITDA before non-recurring items, % | 19.5 | 24.1 | 23.9 | 25.0 |
| EBITDA | 25.2 | 17.0 | 106.2 | 98.0 |
| EBITDA, % | 19.5 | 12.2 | 19.0 | 17.2 |
| EBIT before non-recurring items | 17.9 | 27.0 | 105.8 | 114.9 |
| EBIT before non-recurring items, % | 13.8 | 19.3 | 18.9 | 20.2 |
| EBIT | 17.9 | 10.3 | 78.1 | 70.5 |
| EBIT, % | 13.8 | 7.4 | 13.9 | 12.4 |
Torshälla, April 24th, 2025.
This information is information that Stille is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-04-24 08:00 CEST.
Contact Details
Torbjörn Sköld
CEO & President
+46 (0)70 316 63 91 | torbjorn.skold@stille.se
About Us
Stille AB (publ) develops, manufactures and markets medical devices for surgeons across the world. Stille was founded in 1841 and is one of the world’s oldest medical device companies. Stille’s main business areas are surgical instruments and c-arm tables. Stille’s surgical instruments are mostly used during different kinds of open surgery. During minimal invasive procedures. the c-arm tables imagiQ2 and Medstone are key products. The company has a strong brand and products of a renowned high-quality. The share is listed on First North Growth Market under the acronym “STIL” with Eminova AB as Certified Adviser, Eminova Fondkommission AB, + 46 8 684 211 10, adviser@eminova.se. For more information, visit www.stille.se.
Attachments
Interim Report Q1 2025